House Judiciary Committee Holds Hearing on Medicines and Intellectual Property
On May 21, the House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet held a hearing titled: “Medicines and IP: Balancing Innovation and Access.” The hearing examined policies and issues around the United States patent system, generic and biosimilar drug competition under the Hatch-Waxman Act, and maintaining domestic innovation in the drug development space.
Related
A federal district court in Georgia issued a sweeping ruling that could potentially undermine the legal foundation of the Medicare Advantage (MA) Star Ratings program and invite additional challenges to policies established through sub-regulatory guidance. The court found that the Centers for Medicare and Medicaid Services (CMS) improperly relied on measures based on data not collected through the statutorily required measurement systems and failed to meet notice-and-comment requirements for certain measures.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
